| Oral rivaroxaban for symptomatic venous thromboembolism. G Agnelli, S Berkowitz, H Bounameaux, H Büller, A Cohen, A Gallus, ... N Engl J Med 363 (26), 2499-510, 2010 | 3873* | 2010 |
| Apixaban for extended treatment of venous thromboembolism G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, A Porcari, ... New England Journal of Medicine, 2012 | 1664 | 2012 |
| Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home MMW Koopman, P Prandoni, F Piovella, PA Ockelford, DPM Brandjes, ... New England Journal of Medicine 334 (11), 682-687, 1996 | 1520 | 1996 |
| Extended use of dabigatran, warfarin, or placebo in venous thromboembolism S Schulman, C Kearon, AK Kakkar, S Schellong, H Eriksson, D Baanstra, ... New England Journal of Medicine 368 (8), 709-718, 2013 | 1342 | 2013 |
| Cardiovascular events and intensity of treatment in polycythemia vera R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ... New England Journal of Medicine 368 (1), 22-33, 2013 | 934 | 2013 |
| D-dimer testing to determine the duration of anticoagulation therapy G Palareti, B Cosmi, C Legnani, A Tosetto, C Brusi, A Iorio, V Pengo, ... New England Journal of Medicine 355 (17), 1780-1789, 2006 | 934 | 2006 |
| Low-molecular weight heparin in the treatment of patients with venous thromboembolism: the Columbus Investigators HR Buller, M Gent, AS Gallus, J Ginsberg, MH Prins, R Baildon, ... The New England journal of medicine 337, 657-662, 1997 | 843* | 1997 |
| Aspirin for Preventing the Recurrence of Venous Thromboembolism C Becattini, G Agnelli, A Schenone, S Eichinger, E Bucherini, M Silingardi, ... New England Journal of Medicine 366 (21), 1959-1967, 2012 | 808 | 2012 |
| Rivaroxaban for thromboprophylaxis in acutely ill medical patients AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ... New England Journal of Medicine 368 (6), 513-523, 2013 | 729 | 2013 |
| Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis S Siragusa, B Cosmi, F Piovella, J Hirsh, JS Ginsberg The American journal of medicine 100 (3), 269-277, 1996 | 598 | 1996 |
| Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry P Knoebl, P Marco, F Baudo, P Collins, A Huth‐Kühne, L Nemes, ... Journal of Thrombosis and Haemostasis, 2012 | 564 | 2012 |
| Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study A Cogo, AWA Lensing, MMW Koopman, F Piovella, S Siragusa, PS Wells, ... Bmj 316 (7124), 17-20, 1998 | 548 | 1998 |
| Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review A Iorio, C Kearon, E Filippucci, M Marcucci, A Macura, V Pengo, ... Archives of internal medicine 170 (19), 1710-1716, 2010 | 471 | 2010 |
| Fondaparinux for the treatment of superficial-vein thrombosis in the legs H Decousus, P Prandoni, P Mismetti, RM Bauersachs, Z Boda, B Brenner, ... New England Journal of Medicine 363 (13), 1222-1232, 2010 | 471 | 2010 |
| Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) HKA Collins P, Baudo F, Knoebl P, Lévesque H, Nemes L, ... blood 120 (1), 47-55, 2012 | 372* | 2012 |
| Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled … E Bernardi, G Camporese, HR Büller, S Siragusa, D Imberti, A Berchio, ... Jama 300 (14), 1653-1659, 2008 | 371 | 2008 |
| Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression … S Siragusa, A Malato, R Anastasio, V Cigna, G Milio, C Amato, M Bellisi, ... Blood, The Journal of the American Society of Hematology 112 (3), 511-515, 2008 | 251 | 2008 |
| The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study P Prandoni, S Siragusa, B Girolami, F Fabris, ... Blood 106 (9), 3049-3054, 2005 | 250 | 2005 |
| Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial MA Crowther, W Ageno, D Garcia, L Wang, DM Witt, NP Clark, ... Annals of Internal Medicine 150 (5), 293-300, 2009 | 211 | 2009 |
| Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients D Caramazza, KH Begna, N Gangat, R Vaidya, S Siragusa, DL Van Dyke, ... Leukemia 25 (1), 82-88, 2011 | 202 | 2011 |
